J Am Acad Dermatol
1985;13(4):636-644.
16. Suaini NHA, Tan CPT, Loo EXL, Tham EH. Global differences in atopic dermatitis. Pediatr Allergy Immunol. 2021;32(1):23-33.
17. Wertenteil S, Strunk A, Garg A. Prevalence estimates for chronic urticaria in the United States: A sex- and age-adjusted population analysis. J Am Acad Dermatol. 2019;81(1):152-156.
18. Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M. Autoimmune chronic spontaneous urticaria: What we know and what we do not know. J Allergy Clin Immunol. 2017;139(6):1772-1781.e1771.
19. Fiebiger E, Hammerschmid F, Stingl G, Maurer D. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest. 1998;101(1):243-251.
20. Metz M, Schütz A, Weller K, et al. Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial. J Allergy Clin Immunol. 2017;140(3):864-867.e865.
21. Ferrucci S, Benzecry V, Berti E, Asero R. Rapid disappearance of both severe atopic dermatitis and cold urticaria following dupilumab treatment. Clin Exp Dermatol. 2020;45(3):345-346.
22. Kulthanan K, Hunnangkul S, Tuchinda P, et al. Treatments of cold urticaria: A systematic review. J Allergy Clin Immunol.2019;143(4):1311-1331.
23. Magerl M, Pisarevskaja D, Church MK, Maurer M, Staubach P, Martus P. Critical temperature threshold measurement for cold urticaria: A randomized controlled trial of H1-antihistamine dose escalation.Br J Dermatol. 2012;166(5):1095-1099.
24. Krause K, Spohr A, Zuberbier T, Church MK, Maurer M. Up-dosing with bilastine results in improved effectiveness in cold contact urticaria.Allergy. 2013;68(7):921-928.
25. Abajian M, Krause K, Church MK, et al. Rupatadine 20 mg and 40 mg are effective in reducing the symptoms of chronic cold urticaria.Acta Derm Venereol. 2016;96(1):56-59.
26. Metz M, Scholz E, Ferrán M, Izquierdo I, Giménez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria.Ann Allergy Asthma Immunol. 2010;104(1):86-92.
27. Maurer M, Altrichter S, Metz M, Zuberbier T, Church MK, Bergmann KC. Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria. J Eur Acad Dermatol Venereol.2018;32(3):e112-e113.
28. Jain SV, Mullins RJ. Cold urticaria: a 20-year follow-up study.J Eur Acad Dermatol Venereol. 2016;30(12):2066-2071.
29. Weller K, Groffik A, Church MK, et al. Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol.2014;133(5):1365-1372, 1372.e1361-1366.